By Editor , 16 October 2026
NEB Wins Co-Exclusive Rights to Sell seqWell's TnX Transposase

Ipswich, Mass. – October 15, 2026 -- New England Biolabs (NEB) has secured co-exclusive rights to sell seqWell's TnX Transposase and the right to manufacture the enzyme and include it in NEB kits and products, under a strategic partnership announced alongside the commercial launch of TnX Transposase (Unloaded).